Ocugenix

Business Services · Pennsylvania, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

79 Woodland Rd, Pittsburgh, Pennsylvania...

Phone Number

(412) 600-6379

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Ocugenix

Ocugenix is a biotechnology company focused on developing therapies for angio-fibrotic diseases of the eye by leveraging the body's natural wound healing mechanisms. The company has identified molecular pathways that, when activated, can resolve inflammation and restore homeostasis, addressing significant unmet needs in conditions such as wet macular degeneration, geographic atrophy, proliferative diabetic retinopathy, and dry eye. Their lead product, OGX-110, selectively activates the CXCR3 pathway to promote regenerative repair and counter chronic inflammation. Ocugenix aims to provide disease-modifying treatments that go beyond symptom management, targeting the underlying processes of these ocular diseases.Explore more
Popular SearchesOcugenixOcugenix CorpSIC Code 87,873NAICS Code 54,541Show more

Ocugenix Org Chart

Sean McDonald, Chief Executive Officer at Ocugenix
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is Ocugenix your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Ocugenix

Compare insights from companies similar to Ocugenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Ocugenix

<$5M
1-10
Private
-
2016
$5.3M
1-10
Private
-
2018
DT
David TierneyPresident & CEO
<$5M
11-50
Private
-
-
Kenneth Lock, Chief Commercial Officer at Sling Therapeutics
Kenneth LockChief Commercial Officer
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2016
SC
Serena ChenChief Financial Officer
<$5M
1-10
Private
$5.3M
2018
JB
Julia BalanovaChief Financial Officer
<$5M
1-10
Private
-
2018
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Ocugenix is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Ocugenix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ocugenix.

Ocugenix Tech Stack

A closer look at the technologies used by Ocugenix

See more technologies

Top Business Services Companies

Frequently Asked Questions Regarding Ocugenix

What is Ocugenix's official website?
Ocugenix's official website is www.ocugenix.com
What is Ocugenix's Revenue?
Ocugenix's revenue is <$5 Million
What is Ocugenix's SIC code?
Ocugenix's SIC: 87,873
What is Ocugenix's NAICS code?
Ocugenix's NAICS: 54,541
How many employees does Ocugenix have?
Ocugenix has 1-10 employees
What industry does Ocugenix belong to?
Ocugenix is in the industry of: Business Services, Research & Development
What is Ocugenix competition?
Ocugenix top competitors include: Oncosting, Eyelivio, TRIO Pharmaceuticals, Lin BioScience
What technology does Ocugenix use?
Some of the popular technologies that Ocugenix uses are: GoDaddy DNS
How do I contact Ocugenix?
Ocugenix contact info: Phone number: (412) 600-6379 Website: www.ocugenix.com
What does Ocugenix do?

Ocugenix is a biotechnology company focused on developing therapies for angio-fibrotic diseases of the eye by leveraging the body's natural wound healing mechanisms. The company has identified molecular pathways that, when activated, can resolve inflammation and restore homeostasis, addressing significant unmet needs in conditions such as wet macul... ar degeneration, geographic atrophy, proliferative diabetic retinopathy, and dry eye. Their lead product, OGX-110, selectively activates the CXCR3 pathway to promote regenerative repair and counter chronic inflammation. Ocugenix aims to provide disease-modifying treatments that go beyond symptom management, targeting the underlying processes of these ocular diseases.Read More

Is Ocugenix a public company?
Ocugenix is private company therefore does not currently have an official ticker symbol
See more information about Ocugenix

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.